Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MERS-CoV Antibodies

(MERS-Coronavirus (MERS-CoV))

Your search for reliable MERS-CoV antibodies ends here. MERS-CoV, known by aliases such as , is an integral part of our antibody range. Whether you're working with Middle East Respiratory Syndrome Coronavirus (MERS-CoV), or other species, our range of MERS-CoV antibodies offer precise detection across diverse samples. These specialized antibodies are tailored for various scientific applications like ELISA, IF, providing you with options like polyclonal, recombinant, and monoclonal antibodies, sourced from different host species such as Mouse. The efficacy of our antibodies is well-established, demonstrated through multiple methods.

Detailed information, including references, images, and validations by other customers, can be found on each product page. Should you require assistance in finding a specific product, our customer service team is ready to assist. Utilize our MERS-CoV antibodies in your research endeavors for dependable MERS-CoV detection.

MERS-CoV antibody (ABIN6952845)

MERS-CoV Reactivity: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) ELISA, IF Host: Mouse Monoclonal 3871 unconjugated

MERS-CoV Antibodies by Reactivity

Find MERS-CoV Antibodies for a variety of species such as anti-Middle East Respiratory Syndrome Coronavirus (MERS-CoV) MERS-CoV. The species listed below are among those available. Click on a link to go to the corresponding products.

MERS-CoV Antibodies by Application

Find MERS-CoV Antibodies validated for a specific application such as ELISA, IF. Some of the available applications are listed below. Click on a link to go to the corresponding products.

MERS-CoV Antibodies by Host

Find MERS-CoV Antibodies with a specific Host. The Host listed below are among those available. Click on a link to go to the corresponding products.

MERS-CoV Antibodies by Clonality

Find available monoclonal or polyclonal MERS-CoV Antibodies. Click on a link to go to the corresponding products.

MERS-CoV Antibodies by Clone

Find MERS-CoV Antibodies with a specific Clone. The Clone listed below are among those available. Click on a link to go to the corresponding products.

Popular MERS-CoV Antibodies

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Application ELISA, IF
Validations
Cat. No. ABIN6952845
Quantity 0.1 mg
Datasheet Datasheet

Latest Publications for our MERS-CoV Antibodies

Folegatti, Bittaye, Flaxman, Lopez, Bellamy, Kupke, Mair, Makinson, Sheridan, Rohde, Halwe, Jeong, Park, Kim, Song, Boyd, Tran, Silman, Poulton, Datoo, Marshal, Themistocleous, Lawrie, Roberts et al.: "Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. ..." in: The Lancet. Infectious diseases, (2020) (PubMed).

Langenmayer, Lülf-Averhoff, Adam-Neumair, Fux, Sutter, Volz: "Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S." in: Biologicals : journal of the International Association of Biological Standardization, Vol. 54, pp. 58-62, (2018) (PubMed).

Zhao, Zhou, Zhang, Chu, Liu, Poon, Chan, Leung, Fai, Lin, Zhang, Jin, Yuen, Zheng: "A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses." in: Scientific reports, Vol. 6, pp. 22008, (2016) (PubMed).

Hart, Dyall, Postnikova, Zhou, Kindrachuk, Johnson, Olinger, Frieman, Holbrook, Jahrling, Hensley: "Interferon-? and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays." in: The Journal of general virology, Vol. 95, Issue Pt 3, pp. 571-7, (2014) (PubMed).

Dyall, Coleman, Hart, Venkataraman, Holbrook, Kindrachuk, Johnson, Olinger, Jahrling, Laidlaw, Johansen, Lear-Rooney, Glass, Hensley, Frieman: "Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection." in: Antimicrobial agents and chemotherapy, Vol. 58, Issue 8, pp. 4885-93, (2014) (PubMed).

You are here:
Support